A Kaplan-Meier survival analysis demonstrated shorter, but non-significant overall (Log Rank: p = 0.429) and cardiovascular survival (Log Rank: p = 0.303) as well as shorter time to death of MI (Log Rank: p = 0.209) or stroke (Log Rank: p = 0.291) after the initiation of dialysis in patients who were homozygous for GSTA1*A alleles compared to carriers of at least one GSTA1*B allele (Figure 2). This evidence concerns the gene GSTA1 and stroke disorder.